Oncology Drug Development and Approval of Systemic Anticancer Therapy by the U.S. Food and Drug Administration

著者: Martell, Robert E., Sermer, David, Getz, Kenneth, Kaitin, Kenneth I.
出版事項 2013

Cost sharing for breast cancer hormone therapy: How do dual eligible patients’ copayment impact adherence

著者: Ma, Siyu, Shepard, Donald S., Ritter, Grant A., Martell, Robert E., Thomas, Cindy Parks
出版年 PLoS One (2021)

Metformin, diabetes, and survival among US veterans with colorectal cancer

著者: Paulus, Jessica K., Williams, Christina D., Cossor, Furha I., Kelley, Michael J., Martell, Robert E.
出版年 Cancer Epidemiol Biomarkers Prev (2016)

Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer – Response to Letter

著者: Paulus, Jessica K., Williams, Christina D., Cossor, Furha I., Kelley, Michael J., Martell, Robert E.
出版年 Cancer Epidemiol Biomarkers Prev (2017)

Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies

著者: Godara, Amandeep, Siddiqui, Nauman S., Hachem, Hilal, Tsichlis, Philip N., Martell, Robert E., Saif, Muhammad Wasif
出版年 J Cell Signal (2020)

The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism

著者: Buglio, Daniela, Mamidipudi, Vidya, Khaskhely, Noor M., Brady, Helen, Heise, Carla, Besterman, Jeffrey, Martell, Robert E., MacBeth, Kyle, Younes, Anas
出版事項 2010

EVALUATION OF THE PHARMACODYNAMIC EFFECTS OF MGCD0103 FROM PRECLINICAL MODELS TO HUMAN, USING A NOVEL HDAC ENZYME ASSAY

著者: Bonfils, Claire, Kalita, Ann, Dubay, Marja, Siu, Lillian L., Carducci, Michael A., Reid, Gregory, Martell, Robert E., Besterman, Jeffrey M., Li, Zuomei
出版事項 2008

Diabetes, Metformin Use, and Colorectal Cancer Survival in Postmenopausal Women

著者: Cossor, Furha Iram, Adams-Campbell, Lucile L., Chlebowski, Rowan T., Gunter, Marc J, Johnson, Karen, Martell, Robert E., McTiernan, Anne, Simon, Michael S., Rohan, Thomas, Wallace, Robert B., Paulus, Jessica K.
出版事項 2013

Phase II Study of the Histone Deacetylase Inhibitor MGCD0103 in Patients with Previously Treated Chronic Lymphocytic Leukemia

著者: Blum, Kristie A., Advani, Anjani, Fernandez, Louis, Van Der Jagt, Richard, Brandwein, Joseph, Kambhampati, Suman, Kassis, Jeannine, Davis, Melanie, Bonfils, Claire, Dubay, Marja, Dumouchel, Julie, Drouin, Michel, Lucas, David M., Martell, Robert E., Byrd, John C.
出版事項 2009

Phase II Study of Mocetinostat (MGCD0103) In Patients with Relapsed and Refractory Classical Hodgkin Lymphoma

著者: Younes, Anas, Oki, Yasuhiro, Bociek, R. Gregory, Kuruvilla, John, Fanale, Michelle, Neelapu, Sattva, Copeland, Amanda, Buglio, Daniela, Galal, Ahmed, Besterman, Jeffrey, Li, Zuomei, Drouin, Michel, Patterson, Tracy, Ward, M. Renee, Paulus, Jessica K., Ji, Yuan, Medeiros, L. Jeffrey, Martell, Robert E.
出版年 Lancet Oncol (2011)

Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors

著者: Siu, Lillian L., Pili, Roberto, Duran, Ignacio, Messersmith, Wells A., Chen, Eric X., Sullivan, Rana, MacLean, Martha, King, Serina, Brown, Shirley, Reid, Gregory K., Li, Zuomei, Kalita, Ann M., Laille, Eric J., Besterman, Jeffrey M., Martell, Robert E., Carducci, Michael A.
出版事項 2008

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

著者: Garcia-Manero, Guillermo, Assouline, Sarit, Cortes, Jorge, Estrov, Zeev, Kantarjian, Hagop, Yang, Hui, Newsome, Willie M., Miller, Wilson H., Rousseau, Caroline, Kalita, Ann, Bonfils, Claire, Dubay, Marja, Patterson, Tracy-Ann, Li, Zuomei, Besterman, Jeffrey M., Reid, Gregory, Laille, Eric, Martell, Robert E., Minden, Mark
出版事項 2008